Sophiris bio stock

See Sophiris Bio price target based on analysts offering 12 month price targets for Sophiris Bio in the last 3 months. Follow SPHS to track price target and stock  11 Mar 2020 Sophiris Bio, Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company's stock is recorded 

Get breaking news and analysis on Sophiris Bio, Inc. (SPHS) stock, price quote and chart, trading and investing tools. Sophiris Bio Inc. (SPHS) Stock Quotes | Nasdaq Mar 14, 2019 · Sophiris Bio Inc. (SPHS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. SPHS Sophiris Bio Inc. — Stock Price and Discussion ... Real-time trade and investing ideas on Sophiris Bio Inc. SPHS from the largest community of traders and investors. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Stock Information | Sophiris

SOPHIRIS BIO INC (SPHS) Stock Price, Quote, History & News ...

SPHS Stock Price & Charts | Sophiris Bio In depth view into SPHS (Sophiris Bio) stock including the latest price, news, dividend history, earnings information and financials. Sophiris Bio Inc. - TheStreet - Stock Market Sophiris Bio (SPHS) Stock Tumbles on Public Offering. By Rachel Aldrich. Aug 23, 2016 10:05 AM EDT. MARKETS. Sophiris Bio (SPHS) Stock Jumps After Drug Trial Meets Goal. By Amanda Albright. BRIEF-Sophiris Bio Announces Nasdaq Delisting - Reuters Mar 10, 2020 · * SOPHIRIS BIO INC - NASDAQ DETERMINED TO DELIST CO’S SHARES FROM NASDAQ STOCK MARKET LLC * SOPHIRIS BIO - CO’S COMMON SHARES WILL BE SUSPENDED FROM NASDAQ EFFECTIVE AT OPEN OF BUSINESS ON

Get breaking news and analysis on Sophiris Bio, Inc. (SPHS) stock, price quote and chart, trading and investing tools.

Sophiris Bio Inc. (SPHS) News – Find the latest company news headlines for Sophiris Bio Inc. and all the companies you research at NASDAQ.com SPHS Sophiris Bio, Inc. Stock Quote - FINVIZ.com Sophiris Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of products for the treatment of urological diseases. The company's primary product candidate is PRX302 (topsalysin), which is in Phase III clinical trial for treatment of lower urinary tract symptoms of benign prostatic hyperplasia (BPH), as well as for SPHS Stock Quote - Sophiris Bio Inc. Price - Nasdaq Stock quote for Sophiris Bio Inc. Common Stock (SPHS) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq. Sophiris Bio Inc. Stock Price (SPHS) | Barron's

SPHS | Sophiris Bio Inc. Stock Price & News - WSJ

Sophiris Bio, Inc. Common Stock (SPHS) Earnings Report ... Sophiris Bio, Inc. is estimated to report earnings on 03/11/2020. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. SPHS Stock Quote - Sophiris Bio, Inc. Stock Price Today Sophiris Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products for the treatment of urological diseases. The firm develops PRX302 as a treatment for the symptoms of benign prostatic hyperplasia which is a non cancerous enlargement of the prostate gland that causes a restriction in urine flow from

The following presents a detailed Sophiris Bio stock price history for your review. To help provide a sense of the short to long-term trend, included is an interactive Sophiris Bio stock chart which you can easily adjust to the time frame of your choosing (e.g. using the scroll bar or pinch and zoom on a touch screen).

Contact Us - Sophiris credible science. incredible therapeutics SPHS:OTC US Stock Quote - Sophiris Bio Inc - Bloomberg Markets Stock analysis for Sophiris Bio Inc (SPHS:OTC US) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Sophiris Bio - SPHS - Stock Price & News | The Motley Fool

SPHS Stock Quote - Sophiris Bio, Inc. Stock Price Today Sophiris Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products for the treatment of urological diseases. The firm develops PRX302 as a treatment for the symptoms of benign prostatic hyperplasia which is a non cancerous enlargement of the prostate gland that causes a restriction in urine flow from SOPHIRIS BIO INC (SPHS) Latest Stock News & Headlines ... Get the latest SOPHIRIS BIO INC (SPHS) stock news and headlines to help you in your trading and investing decisions. SPHS | Sophiris Bio Inc. Stock Price & News - WSJ